PD-1 modulates steady-state and infection-induced IL-10 production in vivo

European Journal of Immunology

Volumn 44, Issue 2, 2014, Pages 469-479

  Mcberry, Cortez ^a,b   Dias, Alexandra ^a   Shryock, Nathaniel ^a   Lampe, Kristin ^a   Gutierrez, Fredy R S ^c   Boon, Louis ^d   Herbert, De'Broski R ^e   Aliberti, Julio ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CENTRO DE INVESTIGACIONES   (Colombia)

^d BIOCEROS   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

IL 10; PD 1; Toxoplasma gondii

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL TYPE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; HOST; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INFLAMMATION; INOCULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPLEEN CELL; STEADY STATE; T LYMPHOCYTE; TACHYZOITE; TISSUE INJURY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

IL-10; PD-1; TOXOPLASMA GONDII;

ANIMALS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; PROGRAMMED CELL DEATH 1 RECEPTOR; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84893615972     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343658     Document Type: Article

References (61)

1. Mashayekhi, M., Sandau, M. M., Dunay, I. R., Frickel, E. M., Khan, A., Goldszmid, R. S., Sher, A. et al., CD8α+ dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 2011. 35: 249-259.
2. Yap, G., Pesin, M. and Sher, A., Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 2000. 165: 628-631.
3. Scharton-Kersten, T., Wynn, T., Denkers, E., Bala, S., Hieny, S., Gazzinelli, R. and Sher, A., In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 1996. 157: 4045-4054.
4. Liu, C., Fan, Y., Dias, A., Esper, L., Corn, R., Bafica, A., Machado, F. et al., Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J. Immunol. 2006. 177: 31-35.
5. Bliss, S., Zhang, Y. and Denkers, E., Murine neutrophil stimulation by Toxoplama gondii antigen drives high level production of IFN-gamma-independent IL-12. J. Immunol. 1999. 163: 2081-2088.
6. Reis e Sousa, C., Hieny, S., Scharton-Kersten, T., Jankovic, D., Charest, H., Germain, R. N. and Sher, A., In vivo microbial stimulation induces rapid CD40 ligand-indepedent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 1997. 186: 1819-1829.
7. Gazzinelli, R., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W. et al., In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996. 157: 798-805.
8. Gazzinelli, R., Wysocka, M., Hayashi, S., Denkers, E., Hieny, S., Casper, P., Trinchieri, G. et al., Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994. 153: 2533-2543.
9. Neyer, L., Gruning, G., Fort, M., Remington, J., Rennick, D. and Hunter, C., Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun. 1997. 65: 1675-1682.
10. Aliberti, J., Serhan, C. and Sher, A., Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 2002. 196: 1253-1262.
11. Hunter, C., Ellis-Neyer, L., Gabriel, K., Kennedy, M., Grabstein, K., Linsley, P. and Remington, J., The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J. Immunol. 1997. 158: 2285-2293.
12. Martins, G., Tadokoro, C., Silva, R., Silva, J. and Rizzo, L., CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi. J. Immunol. 2004. 172: 4893-4901.
13. Murphy, M., Cotterell, S., Gorak, P., Engwerda, C. and Kaye, P., Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol. 1998. 161: 4153-4160.
14. Rowe, J., Johanns, T., Ertelt, J., Lai, J. and Way, S., Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge. Immunology 2009. 128: e471-e478.
15. Sharpe, A. H., Wherry, E. J., Ahmed, R. and Freeman, G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007. 8: 239-245.
16. Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H. et al., PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 2009. 113: 5811-5818.
17. Huang, X., Venet, F., Wang, Y., Lepape, A., Yuan, Z., Chen, Y., Swan, R. et al., PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. PNAS 2009. 106: 6308-6308.
18. Benedict, C., Loewendorf, A., Garcia, Z., Blazar, B. and Janssen, E., Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J. Immunol. 2008. 180: 4836-4847.
19. Brown, K. E., Freeman, G. J., Wherry, E. J. and Sharpe, A. H., Role of PD-1 in regulating acute infections. Curr. Opin. Immunol. 2010. 22: 397-401.
20. Lazar-Molnar, E., Chen, B., Sweeney, K., Wang, E., Liu, W., Lin, J., Porcelli, S. et al., Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. PNAS 2010. 107: 13402-13407.
21. Barber, D., Mayer-Barber, K., Feng, C., Sharpe, A. and Sher, A., CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 2011. 186: 1598-1607.
22. Gutierrez, F., Marioano, F., Oliveir, C., Pavanelli, W., Guedes, P., Silva, G., Campanelli, A. et al., Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1. Infect Immun. 2011. 79: 1873-1881.
23. Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T. and Honjo, T., PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 2003. 198: 39-50.
24. Goldszmid, Romina S., Casper, P., Rivollier, A., White, S., Dsutsev, A., Hieny, S., Kelsall, B. et al., NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 2012. 36: 1047-1059.
25. Reis e Sousa, C., Yap, G., Schulz, O., Rogers, N., Schito, M., Aliberti, J., Hieny, S. et al., Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 1999. 11: 637-647.
26. Reis e Sousa, C., Yap, G., Schulz, O., Rogers, N., Schito, M., Aliberti, J., Hieny, S. et al., Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 1999. 11: 637-647.
27. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N. and Sher, A., Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 2002. 3: 76-82.
28. D'Andrea, A., Aste-Amezaga, M., Valiante, N., Ma, X., Kubin, M. and Trinchieri, G., Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 1993. 178: 1041-1048.
29. Aste-Amezaga, M., Ma, X., Sartori, A. and Trinchieri, G., Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 1998. 160: 5936-5944.
30. Finkelman, F. and Morris, S., Development of an assay to measure in vivo cytokine production in the mouse. Int. Immunol. 1999. 11: 1811-1818.
31. Saraiva, M. and O'Garra, A., The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010. 10: 170-181.
32. Madan, R., Demircik, F., Surianarayanan, S., Allen, J., Divanovic, S., Trompette, A., Yogev, N. et al., Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 2009. 183: 2312-2320.
33. Gazzinelli, R., Oswald, I., James, S. and Sher, A., IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 1992. 148: 1792-1796.
34. Hunter, C., Subauste, C., Van Cleave, V. and Remington, J., Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun. 1994. 62: 2818-2824.
35. Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W. et al., In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996. 157: 798-805.
36. Denkers, E. and Gazzinelli, R., Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 1998. 11: 569-588.
37. Cooper, A. and Khader, S., The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 2008. 226: 191-204.
38. Mocci, S. and Dalrymple, S., The cytokine stew and innate resistance to L. monocytogenes. Immunol. Rev. 1997. 158: 107-114.
39. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3: 133-146.
40. Cho, H., Choi, E., Lee, S., Jung, K., Seo, S., Choi, I., Park, S. et al., Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells. Immunol. Lett. 2009. 127: 39-47.
41. Bhadra, R., Gigley, J. P. and Khan, I. A., PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection. J. Infect Dis. 2012. 206: 125-134.
42. Bhadra, R., Gigley, J. P., Weiss, L. M. and Khan, I. A., Control of toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. USA 2011. 108: 9196-9201.
43. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 2001. 19: 683-765.
44. Perona-Wright, G., Morhs, K., Szaba, F., Kummer, L., Madan, R., Karp, C., Johnson, L. et al., Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 2006. 6: 503-512.
45. Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A., Farina, E., Alberoni, M. et al., A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease. Neurobiol. Aging 2012. 33: 624 e611-e622.
46. Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R. et al., Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 2003. 9: 562-567.
47. Bodhankar, S., Chen, Y., Vandenbark, A. A., Murphy, S. J. and Offner, H., PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J. Neuroinflammation 2013. 10: 111.
48. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S. et al., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291: 319-322.
49. Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141-151.
50. Kawamoto, S., Tran, T., Maruya, M., Suzuki, K., Doi, Y., Tsutsui, Y., Kato, L. et al., The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 2012. 336: 485-489.
51. Maynard, C., Harrington, L., Janowski, K., Oliver, J., Zindl, C., Rudensky, A. and Weaver, C., Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 2007. 8: 931-941.
52. Kamanaka, M., Kim, S., Wan, Y., Sutterwala, F., Lara-Tejero, M., Galan, J., Harhaj, E. et al., Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knock in tiger mouse. Immunity 2006. 25: 941-952.
53. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. and Roncarolo, M., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737-742.
54. Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L. et al., PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 2006. 203: 2281-2292.
55. Trautmann, L., Janbazian, L., Chomont, N., Said, E., Gimmig, S., Bessette, B., Boulassel, M. et al., Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 2006. 12: 1198-1202.
56. Kee, S., Kwon, Y., Park, Y., Cho, Y., Lee, S., Kim, T., Lee, S. et al., Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection. Infect Immun. 2012. 80: 2100-2108.
57. Alvarez, I., Pasquinelli, V., Jurado, J., Abbate, E., Musella, R., de la Barrera, S. and Garcia, V., Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J. Infect Dis. 2010. 202: 524-532.
58. Nishimura, H., Minato, N., Nakano, T. and Honjo, T., Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 1998. 10: 1563-1572.
59. Grunvald, E., Chiaramonte, M., Hieny, S., Wysocka, M., Trinchieri, G., Vogel, S., Gazzinelli, R. et al., Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun. 1996. 64: 2010-2018.
60. Pollard, A. M., Skariah, S., Mordue, D. G. and Knoll, L. J., A transmembrane domain-containing surface protein from Toxoplasma gondii augments replication in activated immune cells and establishment of a chronic infection. Infect Immun. 2009. 77: 3731-3739.
61. Wilson, D. C., Grotenbreg, G. M., Liu, K., Zhao, Y., Frickel, E. M., Gubbels, M. J., Ploegh, H. L. et al., Differential regulation of effector- and central-memory responses to Toxoplasma gondii infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog. 2010. 6: e1000815.